/term/ebit-per-share/NUVO NUVO (Holdco Nuvo Group DG) EBIT per Share
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » EBIT per Share

Holdco Nuvo Group DG (Holdco Nuvo Group DG) EBIT per Share : $ (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG EBIT per Share?

Holdco Nuvo Group DG's EBIT per Share for the six months ended in Dec. 2023 was $-1.04. Holdco Nuvo Group DG does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Holdco Nuvo Group DG's EBIT per Share or its related term are showing as below:

NUVO's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Holdco Nuvo Group DG's EBIT for the six months ended in Dec. 2023 was $-34.65 Mil.


Holdco Nuvo Group DG EBIT per Share Historical Data

The historical data trend for Holdco Nuvo Group DG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG EBIT per Share Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
EBIT per Share
-1.01 -0.60 -1.04

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Dec22 Dec23
EBIT per Share -1.01 -0.60 -1.04

Holdco Nuvo Group DG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Holdco Nuvo Group DG's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-34.65/33.262
=-1.04

Holdco Nuvo Group DG's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

EBIT per Share(Q: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-34.65/33.262
=-1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holdco Nuvo Group DG  (NAS:NUVO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Holdco Nuvo Group DG EBIT per Share Related Terms

Thank you for viewing the detailed overview of Holdco Nuvo Group DG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines